Certified by Founder Lodge
ClavystBio
Singapore - Singapore
INVESTOR
1 Disclosed Funding Rounds $27,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ClavystBio is a life sciences venture investor set up by Temasek.
Our mission is to accelerate the commercialization of life sciences breakthroughs into health impact. We invest and partner
| Company | Date | Round | Raised |
|---|---|---|---|
 Engine Biosciences |
November, 01 ,2023 | Series A | $27,000,000 |
 Callio Therapeutics |
March, 06 ,2025 | Series A | $187,000,000 |
 Allay Therapeutics |
June, 06 ,2025 | Series D | $57,500,000 |
 Cirrus Therapeutics |
October, 07 ,2025 | Seed | $11,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Bland Company | $2,670,000 | (Feb 18, 2026)
Tangible | $4,300,000 | (Feb 18, 2026)
Helia Care, Inc. | $3,000,000 | (Feb 18, 2026)
Daffodil Health Corp | $16,300,000 | (Feb 18, 2026)
FYLD | $41,000,000 | (Feb 18, 2026)
